Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,229.37
+8.240.67%
Number of Gainers:6
Number of Losers:1
Number of Flat:- -
PE:- -
High:1,240.78
Open:1,222.44
Low:1,222.44
Close:1,221.13
Loading ...

Pfizer: on Track to Exceed Net Cost Savings Targets

THOMSON REUTERS
·
29 Apr

Pfizer: No Share Repurchases Have Been Completed to Date in 2025

THOMSON REUTERS
·
29 Apr

Pfizer: Current Financial Guidance Does Not Anticipate Any Share Repurchases in 2025

THOMSON REUTERS
·
29 Apr

Pfizer Inc - Additional $1.2 Bln Cost Savings Expected by End 2027

THOMSON REUTERS
·
29 Apr

Pfizer Q1 Net Income USD 2,967 Million

THOMSON REUTERS
·
29 Apr

Pfizer Q1 Adjusted EPS USD 0.92 VS. Ibes Estimate USD 0.66

THOMSON REUTERS
·
29 Apr

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

Business Wire
·
29 Apr

The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron

Zacks
·
29 Apr

Share Prices of These 4 US Growth Stocks Are at 52-Week Lows: Are They a Bargain?

The Smart Investor
·
29 Apr

Stocks to Watch Tuesday: GM, Porsche, Coca-Cola -- WSJ

Dow Jones
·
29 Apr

Zacks.com featured highlights StoneCo, Carriage Services, Associated Banc-Corp and Pfizer

Zacks
·
29 Apr

Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga
·
29 Apr

Pantera Lithium Advances Smackover Project Amid New Arkansas Legislation

TIPRANKS
·
29 Apr

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

GlobeNewswire
·
29 Apr

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

PR Newswire
·
29 Apr

Notable companies reporting before tomorrow’s open

TIPRANKS
·
29 Apr

Pfizer (NYSE:PFE) Unveils Promising Preclinical Data On First-In-Class Oncology Drug

Simply Wall St.
·
29 Apr

HSBC cuts biotech stocks: Eli Lilly lowered to Reduce

Investing.com
·
28 Apr

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
28 Apr

Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs

GuruFocus.com
·
28 Apr